Associations of Community and Individual Social Determinants of Health With Medication Adherence in Patients With Atrial Fibrillation: A Retrospective Cohort Study

被引:5
作者
Boyd, Lisa M. [1 ]
Colavecchia, Anthony Carmine [2 ,4 ]
Townsend, Kevin A. [2 ]
Kmitch, Laura [1 ]
Broder, Leah [1 ]
Hegeman-Dingle, Rozelle R. [2 ]
Ateya, Mohammad [2 ]
Lattimer, Alan [1 ]
Bosch, Ryan [1 ]
Alvir, Jose [3 ]
机构
[1] Socially Determined Inc, Washington, DC USA
[2] Pfizer Inc, US Med Affairs, New York, NY USA
[3] US Stat Res & Data Sci Ctr, Pfizer Inc, Global Prod Dev, New York, NY USA
[4] Pfizer Inc, 4037 Pleasant Ridge Dr, Spring, TX 77386 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 08期
关键词
anticoagulants; atrial fibrillation; medication adherence; social determinants of health; social risk factors; FOOD INSECURITY; RISK-FACTOR; HIV; STROKE;
D O I
10.1161/JAHA.122.026745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDespite guideline-recommended use of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), OAC medication adherence among patients with AF in the United States ranges from 47% to 82%. To characterize potential causes of nonadherence, we analyzed associations between community and individual social risk factors and OAC adherence for stroke prevention in AF. Methods and ResultsA retrospective cohort analysis of patients with AF was conducted using the IQVIA PharMetrics Plus claims data from January 2016 to June 2020, and 3-digit ZIP code-level social risk scores were calculated using American Community Survey and commercial data. Logistic regression models evaluated associations between community social determinants of health, community social risk scores for 5 domains (economic climate, food landscape, housing environment, transportation network, and health literacy), patient characteristics and comorbidities, and 2 adherence outcomes: persistence on OAC for 180 days and proportion of days covered >= 0.80 at 360 days. Of 28 779 patients with AF included in the study, 70.8% of patients were male, 94.6% were commercially insured, and the average patient age was 59.2 years. Multivariable regression found that greater health literacy risk was negatively associated with 180-day persistence (odds ratio [OR]=0.80 [95% CI, 0.76-0.83]) and 360-day proportion of days covered (OR, 0.81 [95% CI, 0.76-0.87]). Patient age and higher AF stroke risk score and AF bleeding risk scores were positively associated with both 180-day persistence and 360-day proportion of days covered. ConclusionsSocial risk domains, such as health literacy, may affect OAC adherence among patients with AF. Future studies should explore associations between social risk factors and nonadherence with greater geographic granularity.
引用
收藏
页数:37
相关论文
共 50 条
  • [21] Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study
    Bartolazzi, Frederico
    Ribeiro, Antonio Luiz Pinho
    de Sousa, Waleska Jaclyn Freitas Nunes
    Vianna, Mayara Sousa
    da Silva, Jose Luiz Padilha
    Martins, Maria Auxiliadora Parreiras
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (04) : 1074 - 1080
  • [22] Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation A Report From the Swedish Atrial Fibrillation Cohort Study
    Friberg, Leif
    Rosenqvist, Marten
    Lip, Gregory Y. H.
    CIRCULATION, 2012, 125 (19) : 2298 - +
  • [23] Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study
    Raparelli, Valeria
    Proietti, Marco
    Butta, Carmelo
    Di Giosia, Paolo
    Sirico, Domenico
    Gobbi, Paolo
    Corrao, Salvatore
    Davi, Giovanni
    Vestri, Anna Rita
    Perticone, Francesco
    Corazza, Gino Roberto
    Violi, Francesco
    Basili, Stefania
    INTERNAL AND EMERGENCY MEDICINE, 2014, 9 (08) : 861 - 870
  • [24] Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study
    Vedovati, Maria Cristina
    Giustozzi, Michela
    Verdecchia, Paolo
    Pierpaoli, Lucia
    Conti, Serenella
    Verso, Melina
    Di Filippo, Francesco
    Marchesini, Emanuela
    Bogliari, Giulio
    Agnelli, Giancarlo
    Becattini, Cecilia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 269 : 152 - 157
  • [25] The impact of medication adherence on health outcomes for chronic metabolic diseases: A retrospective cohort study
    Han, Euna
    Suh, Dong-Churl
    Lee, Seung-Mi
    Jang, Sunmee
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (06) : E87 - E98
  • [26] Utilizing Social Determinants of Health Model to Understand Barriers to Medication Adherence in Patients with Ischemic Stroke: A Systematic Review
    Ruksakulpiwat, Suebsarn
    Benjasirisan, Chitchanok
    Ding, Kedong
    Phianhasin, Lalipat
    Thorngthip, Sutthinee
    Ajibade, Anuoluwapo
    Thampakkul, Jai
    Zhang, Amy Y.
    Voss, Joachim G.
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2161 - 2174
  • [27] Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study
    Rahme, Elham
    Godin, Richard
    Nedjar, Hacene
    Dasgupta, Kaberi
    Tagalakis, Vicky
    THROMBOSIS RESEARCH, 2021, 203 : 121 - 130
  • [28] Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
    Perreault, Sylvie
    de Denus, Simon
    White-Guay, Brian
    Cote, Robert
    Schnitzer, Mireille E.
    Dube, Marie-Pierre
    Dorais, Marc
    Tardif, Jean-Claude
    PHARMACOTHERAPY, 2020, 40 (01): : 40 - 54
  • [29] Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
    Srikajornlarp, Saowaluk
    Amnueypol, Montawatt
    Vathesatogkit, Prin
    Numthavaj, Pawin
    Ungkanont, Artit
    Likittanasombat, Khanchit
    Pattanaprateep, Oraluck
    Angchaisuksiri, Pantep
    Boonyawat, Kochawan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [30] Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
    Srikajornlarp, Saowaluk
    Amnueypol, Montawatt
    Vathesatogkit, Prin
    Numthavaj, Pawin
    Ungkanont, Artit
    Likittanasombat, Khanchit
    Pattanaprateep, Oraluck
    Angchaisuksiri, Pantep
    Boonyawat, Kochawan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28